News

Gantenerumab improved markers of disease in rare, inherited form of Alzheimer’s disease

Further analysis of data from an international trial of two investigational drugs in people in the early stages of a...

In DIAN-TU, Gantenerumab Brings Down Tau. By a Lot. Open Extension Planned

Alzforum - Apr 10, 2020

Confused About the DIAN-TU Trial Data? Experts Discuss Nuances

Alzforum - Apr 10, 2020

Topline Result for First DIAN-TU Clinical Trial: Negative on Primary

Alzforum - Feb 10 2020

Investigational drugs didn’t slow memory loss, cognitive decline in rare, inherited Alzheimer’s, initial analysis indicates

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE NEWS RELEASE - FEB 10 2020

Major Alzheimer’s study to open 5 new Latin American sites

Washington University School of Medicine news release - Nov 20 2019

Why Didn’t She Get Alzheimer’s? The Answer Could Hold a Key to Fighting the Disease

New York Times - Nov 4 2019

‘Reports of My Death Are Greatly Exaggerated.’ Signed, Aducanumab

Alzforum - Oct 24 2019

Wash U leading worldwide Alzheimer’s study

KSDK - ST. LOUIS LOCAL NEWS, OCTOBER 15, 2019

The importance of prevention trials in Alzheimer’s disease with Randall Bateman

Neuro Central, September 23, 2019